Your browser is no longer supported. Please, upgrade your browser.
Settings
LCI Lannett Company, Inc. daily Stock Chart
LCI [NYSE]
Lannett Company, Inc.
Index- P/E- EPS (ttm)-0.03 Insider Own2.40% Shs Outstand37.17M Perf Week-8.31%
Market Cap615.16M Forward P/E6.02 EPS next Y2.75 Insider Trans0.00% Shs Float28.11M Perf Month5.75%
Income-0.60M PEG- EPS next Q0.52 Inst Own90.50% Short Float59.61% Perf Quarter-12.20%
Sales637.30M P/S0.97 EPS this Y-101.30% Inst Trans-7.75% Short Ratio28.91 Perf Half Y-20.43%
Book/sh15.21 P/B1.09 EPS next Y7.05% ROA0.00% Target Price23.00 Perf Year-49.05%
Cash/sh3.90 P/C4.25 EPS next 5Y-9.64% ROE-0.10% 52W Range14.90 - 33.53 Perf YTD-24.94%
Dividend- P/FCF3.72 EPS past 5Y-16.10% ROI5.80% 52W High-50.64% Beta2.76
Dividend %- Quick Ratio2.10 Sales past 5Y39.00% Gross Margin47.90% 52W Low11.07% ATR0.78
Employees1126 Current Ratio2.70 Sales Q/Q-17.60% Oper. Margin13.60% RSI (14)38.10 Volatility4.46% 4.64%
OptionableYes Debt/Eq1.61 EPS Q/Q58.80% Profit Margin-0.10% Rel Volume0.49 Prev Close16.85
ShortableYes LT Debt/Eq1.50 EarningsAug 23 AMC Payout- Avg Volume579.54K Price16.55
Recom2.40 SMA20-3.16% SMA50-9.43% SMA200-21.04% Volume282,621 Change-1.78%
Jun-29-16Initiated Deutsche Bank Hold $26
Mar-24-16Downgrade Canaccord Genuity Buy → Sell $28 → $18
Feb-04-16Upgrade Craig Hallum Hold → Buy
Nov-05-15Downgrade Craig Hallum Buy → Hold
Sep-03-15Reiterated ROTH Capital Buy $61 → $68
Jul-21-15Initiated Susquehanna Positive
Feb-05-15Reiterated ROTH Capital Buy $54 → $61
Nov-24-14Reiterated ROTH Capital Buy $66 → $60
Nov-04-14Reiterated ROTH Capital Buy $53 → $66
Nov-04-14Reiterated Canaccord Genuity Buy $55 → $73
Nov-04-14Downgrade Oppenheimer Outperform → Perform $53
Oct-13-14Reiterated Oppenheimer Outperform $51 → $53
Jul-15-14Reiterated Oppenheimer Outperform $49 → $52
May-06-14Resumed Canaccord Genuity Buy $55
Feb-10-14Reiterated Canaccord Genuity Buy $29 → $55
Feb-07-14Reiterated Oppenheimer Outperform $41 → $45
Sep-11-13Reiterated Oppenheimer Outperform $15 → $20
May-23-13Initiated Needham Buy $15
Feb-08-13Reiterated Oppenheimer Outperform $6 → $9
Sep-08-11Reiterated Oppenheimer Outperform $7 → $6
Sep-13-17 07:00AM  Earnings Review and Free Research Report: Lannetts Sales and Earnings Results Met Expectations ACCESSWIRE
Sep-06-17 05:02PM  What Is Lannett Company Incs (LCI) Share Price Doing? Simply Wall St.
Sep-05-17 03:30PM  Lannett receives FDA OK for generic Nexium product American City Business Journals
09:45AM  Lannett Scores FDA OK for Nexium Generic-Biotech Movers TheStreet.com
06:53AM  Lannett Receives Approval For Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg And 40 mg PR Newswire
Sep-01-17 08:10PM  ETFs with exposure to Lannett Co., Inc. : September 2, 2017 Capital Cube
Aug-30-17 01:30PM  Lannett Co., Inc. :LCI-US: Earnings Analysis: 2017 By the Numbers : August 30, 2017 Capital Cube
Aug-24-17 08:26PM  Edited Transcript of LCI earnings conference call or presentation 23-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
10:57AM  Lannett (LCI) Q4 Earnings In Line, Stock Up on Solid View Zacks
Aug-23-17 09:46PM  Lannett posts 4Q profit Associated Press
04:24PM  Lannett Reports Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Provides Guidance For Fiscal 2018 PR Newswire
10:00AM  Investor Network: Lannett Company, Inc. to Host Earnings Call ACCESSWIRE
Aug-15-17 06:06PM  Lannett Co., Inc. Value Analysis (NYSE:LCI) : August 15, 2017 Capital Cube
Aug-08-17 06:54AM  Lannett Announces Preliminary Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Comments On Fiscal 2018 Outlook PR Newswire
Aug-07-17 04:21PM  3 Stocks Hitting 52-Week Lows: Time to Go Bargain Shopping? Motley Fool
Aug-05-17 08:27AM  Teva, Mylan Seen to Stay on M&A Sidelines TheStreet.com
Aug-03-17 07:02AM  Take a Look at 5 Stocks with Attractive Price-to-Book Ratio Zacks -8.00%
Aug-02-17 11:29AM  Zacks.com featured highlights: Vishay Intertechnology, Big Lots, Applied Materials and Lannett Company Zacks -6.95%
09:14AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : August 2, 2017 Capital Cube
Aug-01-17 08:08AM  4 Low Price-to-Cash-Flow Stocks for Assured Returns Zacks
06:53AM  Lannett To Present At The Canaccord Genuity 37th Annual Growth Conference On August 9 PR Newswire
Jul-24-17 04:57PM  ETFs with exposure to Lannett Co., Inc. : July 24, 2017 Capital Cube
Jul-17-17 09:01AM  Fox Rothschild partner becomes general counsel of local drug manufacturer American City Business Journals
07:20AM  Corporate News Blog - Lannett Co. Receives Approval for Cyproheptadine Hydrochloride Syrup Accesswire
06:53AM  Lannett Appoints Samuel H. Israel As General Counsel PR Newswire
Jul-14-17 06:53AM  Lannett Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL PR Newswire +6.57%
Jul-12-17 02:46PM  ETFs with exposure to Lannett Co., Inc. : July 12, 2017 Capital Cube
Jul-04-17 08:57AM  Lannett Co., Inc. breached its 50 day moving average in a Bullish Manner : LCI-US : July 4, 2017 Capital Cube
Jun-28-17 08:15AM  Corporate News Blog - Lannett Receives Approval for Additional Dosage Strengths of Hydrocodone Bitartrate and Acetaminophen Tablets USP Accesswire
Jun-26-17 06:51AM  Lannett Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets USP PR Newswire
Jun-22-17 06:53AM  Lannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/300 mg, 7.5 mg/300 mg And 10 mg/300 mg PR Newswire
Jun-20-17 06:52AM  Lannett Names Patrick G. LePore To Board of Directors PR Newswire
Jun-19-17 03:38PM  ETFs with exposure to Lannett Co., Inc. : June 19, 2017 Capital Cube
08:15AM  Featured Company News - Lannett Announces Approval for Amantadine Hydrochloride Capsules USP, 100 mg; Set to Launch Before the Flu Season Accesswire
06:53AM  Lannett Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And 1000 Mg PR Newswire
Jun-16-17 11:49AM  Lannett Co., Inc. :LCI-US: Earnings Analysis: Q3, 2017 By the Numbers : June 16, 2017 Capital Cube
06:53AM  Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg PR Newswire
May-26-17 06:53AM  Lannett Company's Chief Executive Officer Receives High Rating PR Newswire
May-16-17 06:52AM  Lannett Announces Approval For Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL (0.5 mg/mL) PR Newswire
May-09-17 06:53AM  Lannett Voluntarily Pays Down Remaining $25 Million Principal Balance Of Revolving Credit Facility PR Newswire
May-05-17 05:08PM  Lannett Co., Inc. Value Analysis (NYSE:LCI) : May 5, 2017 Capital Cube
May-04-17 02:16PM  Edited Transcript of LCI earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents
08:53AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : May 4, 2017 Capital Cube
May-03-17 01:07PM  Here's Why Lannett Company, Inc. Is Having a Lousy Day Motley Fool -18.60%
12:46PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
08:53AM  Perrigo Stock Sliding on DOJ Search TheStreet.com
May-02-17 07:41PM  Lannett misses Street 3Q forecasts Associated Press
04:15PM  Lannett Reports Fiscal 2017 Third-Quarter Financial Results PR Newswire
Apr-28-17 06:54AM  Lannett To Participate At Three Investor Conferences In May PR Newswire
Apr-25-17 06:54AM  Lannett To Report Fiscal 2017 Third-Quarter Financial Results, Host Conference Call On Tuesday, May 2 PR Newswire
Apr-24-17 09:40AM  Lawsuit for Investors in NYSE: LCI Shares against Lannett Company, Inc Announced by Shareholders Foundation Accesswire
Apr-10-17 04:31PM  Akorn Acquisition Talks Send Generic Drugmakers Into Orbit Investor's Business Daily +10.59%
Apr-04-17 08:23AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : April 4, 2017 Capital Cube
08:23AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : April 4, 2017
Apr-03-17 12:14PM  Lannett Refuses to Go Lower TheStreet.com
12:14PM  Lannett Refuses to Go Lower
Mar-30-17 06:53AM  Lannett Voluntarily Pays Down Additional $25 Million Of Revolving Credit Facility PR Newswire
Mar-29-17 11:31AM  Trading Five Volatility Squeeze Plays
Mar-27-17 06:54AM  Lannett Announces Passing Of Former Chairman And Chief Executive Officer William Farber PR Newswire
Mar-24-17 02:43PM  3 Top Generic Drug Companies to Buy in 2017 Motley Fool
02:43PM  3 Top Generic Drug Companies to Buy in 2017 at Motley Fool
Mar-21-17 09:40AM  Is Lannett (LCI) a Great Stock for Value Investors? Zacks
09:40AM  Is Lannett (LCI) a Great Stock for Value Investors?
Mar-20-17 08:19AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : March 20, 2017 Capital Cube
08:19AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : March 20, 2017
Mar-10-17 09:30AM  The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems Zacks
09:30AM  The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems
Feb-27-17 06:53AM  Lannett To Participate At Four Upcoming Investor Conferences PR Newswire
Feb-23-17 06:53AM  Lannett Announces Addition To Management Team PR Newswire
Feb-22-17 11:25AM  FDA gives Lannett more time to make its case for ADHD drug at bizjournals.com
06:54AM  Lannett Provides Further Update On Methylphenidate ER Tablets PR Newswire
Feb-16-17 10:13AM  Will Lannett (LCI) Continue to Surge Higher?
Feb-13-17 12:55PM  Weekly CEO Buys Highlights
Feb-08-17 05:18PM  CEO Buys Shares of Lannett
01:04PM  LANNETT CO INC Financials
Feb-07-17 11:23AM  Lannett Co., Inc. :LCI-US: Earnings Analysis: Q2, 2017 By the Numbers : February 7, 2017
10:22AM  Will Q4 Earnings Hold a Surprise for DaVita (DVA) Stock?
09:15AM  Board Member at Beleaguered Burrito Chain Buys Shares After Barrons Releases Grim Cover Story, Plus Other Noteworthy Insider Trading Activity at Insider Monkey
06:54AM  Lannett Announces Successful Completion Of ERP System Extraction PR Newswire
Feb-06-17 08:20AM  Affimed (AFMD) Shows Strength: Stock Moves 8.1% Higher
08:00AM  AcelRx Pharmaceuticals (ACRX) in Focus: Stock Rises 5.3%
Feb-03-17 08:57AM  LANNETT CO INC Files SEC form 10-Q, Quarterly Report -8.06%
Feb-02-17 04:16PM  LANNETT CO INC Files SEC form 8-K, Results of Operations and Financial Condition
Feb-01-17 10:39PM  Edited Transcript of LCI earnings conference call or presentation 1-Feb-17 9:30pm GMT
05:48PM  Lannett tops Street 2Q forecasts
04:15PM  Lannett Reports Fiscal 2017 Second-Quarter Financial Results PR Newswire
07:07AM  Q2 2017 Lannett Company Inc Earnings Release - After Market Close
Jan-30-17 01:42PM  5 Earnings Short-Squeeze Trade Ideas
Jan-25-17 08:11PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Lannett Company, Inc. -LCI PR Newswire
05:03PM  LANNETT CO INC Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders
06:54AM  Lannett To Report Fiscal 2017 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 1 PR Newswire
Jan-23-17 03:05PM  Robbins Arroyo LLP: Lannett Company, Inc. (LCI) Misled Shareholders According to a Recently Filed Class Action Business Wire
08:27AM  Lannett Voluntarily Pays Down $75 Million Of Revolving Credit Facility PR Newswire
Jan-19-17 05:34PM  LANNETT CO INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
03:03PM  Lifshitz & Miller Law Firm Announces Investigation of Ally Financial Inc., Amphastar Pharmaceuticals, Inc., Lannett Company, Inc., Live Ventures Incorporated, MiMedx Group, Inc., Seattle Genetics, Inc., Teligent, Inc., TerraVia Holdings, In PR Newswire
Jan-13-17 02:49PM  Harwood Feffer LLP Announces Investigation of Lannett Company Inc. PR Newswire
11:40AM  Bernstein Liebhard LLP Announces That Only Four Days Remain To File A Motion For Lead Plaintiff In A Class Action Suit Against Lannett Company, Inc. PR Newswire
10:47AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Lannett Company, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 Business Wire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017 GlobeNewswire
Jan-12-17 05:10PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Lannett Company, Inc. - LCI PR Newswire
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. It also provides its products for various medical indications comprising glaucoma, cholesterol, muscle spasm, migraine, pain management, cardiovascular, antipsychosis, gastrointestinal, urinary, bronchospasms, respiratory, gallstone, congestive heart failure, thyroid deficiency, central nervous system, and gout. In addition, the company manufactures active pharmaceutical ingredients; markets its products under the Diamox, Lipitor, Lioresal, Fioricet, Fiorinal, Lanoxin, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Metadate CD, Concerta, Procardia, Prilosec, Ditropan, Protonix, Imitrex, Brethine, Tussionex, and Actigall brands. Further, it sells pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with JSP, Summit Bioscience LLC, HEC Pharm Group, and Pharma Pass II LLC. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BEDROSIAN ARTHUR PCEOFeb 06Buy20.0010,000200,000688,909Feb 06 05:14 PM
FARBER DAVID10% OwnerDec 13Sale25.002005,0001,930,870Dec 15 04:28 PM
FARBER DAVID10% OwnerDec 09Sale25.306,000151,8001,931,070Dec 15 04:28 PM
FARBER DAVID10% OwnerDec 02Sale25.003,80095,0001,937,070Dec 05 04:29 PM
FARBER JEFFREYDirectorNov 07Option Exercise6.895,00034,4502,438,826Nov 08 05:49 PM